InvestorsHub Logo
Followers 14
Posts 649
Boards Moderated 0
Alias Born 04/03/2014

Re: XenaLives post# 94959

Friday, 03/10/2017 12:30:23 PM

Friday, March 10, 2017 12:30:23 PM

Post# of 461943
The Japanese will get 273 on the market quick (assuming all trials and testing are adequate) ..... and likely avxl and it's BOD will see that speed as a huge advantage..... A partnership with the wrong company could tie things up also.... Japan (or Austrailia ) partnership would be the best for patients and avxl shareholders IMO.... and then get a US generics partner (Mylan?) for US distribution....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News